Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair.

‘A compelling alternative’: Polymer heart valve receives first commercial approval of its kind
A new surgical mitral valve from Foldax will now be commercially available in India. The valve is built using LifePolymer, a proprietary material that does not include animal tissue.
Heart surgeons perform world’s first robotic TAVR explant and aortic valve replacement
The patient, 67, presented with a failing TAVR valve and a leaky mitral valve. She had undergone TAVR four years prior, but premature structural valve degeneration made a full replacement necessary. Surgeons ultimately removed the TAVR valve in addition to replacing her aortic and mitral valves—all with the help of advanced robotics.
FDA approves self-expanding Tendyne TMVR device from Abbott
The self-expanding valve, which gained CE mark approval back in 2020, is available in multiple sizes and can be fully retrieved and repositioned as it is implanted.
Permanent pacemaker implantation after mitral valve surgery: Exploring the impact on long-term survival
PPMI after aortic valve surgery is known to increase certain risks for patients, but its impact after mitral valve procedures is unclear. A team of researchers aimed to learn more, tracking data from more than 4,500 patients.
LVOT modification during robotic mitral valve repair limits complications
While LVOT modification does make these procedures longer, it can help high-risk patients avoid systolic anterior motion.

New guidelines focus on the management of heart failure patients with secondary mitral regurgitation

The Heart Failure Association, European Association of Cardiovascular Imaging, European Heart Rhythm Association and European Association of Percutaneous Cardiovascular Interventions all collaborated on the position statement.

Edwards evaluating the safety, effectiveness of new mitral valve repair solution

The system was designed to require only one small incision to repair a patient’s mitral valve.

MitraClip an effective bridge strategy for advanced heart failure patients waiting for a heart transplant

The findings were presented Friday, Oct. 16, at TCT Connect 2020.

Promising outcomes reported for transcatheter mitral valve-in-valve replacement

The overall procedural technical success rate, researchers reported, was 96.8%.

CV societies ‘very concerned’ about proposed coverage changes for MR therapy

The American College of Cardiology, Society of Thoracic Surgeons, American Association for Thoracic Surgery and Society for Cardiovascular Angiography and Interventions all collaborated on the response.

Is volume an accurate measure of success when it comes to mitral valve surgery?

Nearly 93% of the U.S. population lives in a hospital referral region with at least one medical center that performs 25 or more mitral valve repairs or replacements each year, according to work published in JAMA Cardiology—but MVRR centers continue to suffer from significant geographical and patient-level disparities.

TMVR with MitraClip increases life expectancy—at a cost

An economic analysis of COAPT data suggests edge-to-edge TMVR with the MitraClip device is a more affordable long-term treatment option than guideline-directed medical therapy alone for patients with severe secondary MR—but the steep cost of an index TMVR procedure might eclipse that benefit.

3-year COAPT results bolster MitraClip’s success

Results from the COAPT study continue to roll in, and it was all positive news for the MitraClip team at the TCT conference in San Francisco this month.

Mitral Valve

‘A compelling alternative’: Polymer heart valve receives first commercial approval of its kind

Heart surgeons perform world’s first robotic TAVR explant and aortic valve replacement

FDA approves self-expanding Tendyne TMVR device from Abbott

Permanent pacemaker implantation after mitral valve surgery: Exploring the impact on long-term survival

LVOT modification during robotic mitral valve repair limits complications